A clinical trial at OHSU and UC San Francisco points the way to potential targeted therapies. The drug enzalutamide is a mainstay of treatment for men with life-threatening prostate cancer that has...
A $10 million gift from The Harry T. Mangurian Jr. Foundation will help The Leukemia & Lymphoma Society expand the Beat AML Master Trial underway at the OHSU Knight Cancer Institute and other...
Preventing skin cancer with a DNA-repair enzyme. Understanding how microRNAs modify cancer immunity. Using zebrafish embryos to rapidly assess toxicity of anticancer drug combinations. These are...
Physicians have started to face up to an uncomfortable truth: their profession has often embraced new treatments that don't really help patients. "When you look at the balance of benefit and harm,...
Phil Knight and Brian Druker, M.D., on "Good Morning America" in 2015. Nike co-founder Phil Knight and his wife Penny ranked no. 1 in The Chronicle of Philanthropy list of Americans who donated...